Sign in

CIK 0001664710 · Non-accelerated filer<br>Smaller reporting company

Keros Therapeutics, Inc.

Sign in to watch
Ticker
KROS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
811173868
Phone
617-314-6297
Business address
1050 WALTHAM STREET, SUITE 302, LEXINGTON, MA, 02421
  1. 8-K Event Regulation FD disclosure
  2. 10-Q Report Quarterly Report
  3. 8-K Event Results of operations
  4. 8-K Event Regulation FD disclosure
  5. 8-K Event Regulation FD disclosure
  6. 8-K Event Other events
  7. 8-K Event Regulation FD disclosure
  8. 10-Q Report Quarterly Report
  9. 8-K Event Results of operations
  10. 8-K Event Regulation FD disclosure
  11. 8-K Event Executive or director change
  12. 8-K Event Executive or director change · Regulation FD disclosure
  13. 8-K Event Shareholder vote results
  14. 8-K Event Regulation FD disclosure
  15. 10-Q Report Quarterly Report
  16. 8-K Event Results of operations
  17. 8-K Event Other events
  18. 8-K Event Regulation FD disclosure
  19. 10-K Report Annual Report
  20. 8-K Event Results of operations

Page 1 of 10 · 183 filings